We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $618B
1-Year Est. Return 30.34%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+22.33%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$385B
AUM Growth
+$32.1B
Cap. Flow
-$35.1B
Cap. Flow %
-9.14%
Top 10 Hldgs %
30.5%
Holding
11,975
New
1,989
Increased
4,461
Reduced
4,218
Closed
1,130

Sector Composition

Rank Sector Weight
1 Technology 3.78%
2 Healthcare 3.27%
3 Industrials 2.02%
4 Financials 2.02%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AENZ
10551
DELISTED
Aenza S.A.A.
AENZ
$35K ﹤0.01%
+4,912
New +$31.7K
GAU
10552
CALL
Galiano Gold
GAU
$565M
$34K ﹤0.01%
30,300
+17,900
+144% +$22.6K
MARPS icon
10553
Marine Petroleum Trust
MARPS
$9.52M
$34K ﹤0.01%
+10,101
New +$31.3K
RETO icon
10554
ReTo Eco-Solutions
RETO
$9.91M
0
RMTI icon
10555
CALL
Rockwell Medical
RMTI
$30.2M
$34K ﹤0.01%
305
+117
+62% +$13.1K
SUPV
10556
Grupo Supervielle
SUPV
$724M
$34K ﹤0.01%
16,050
-6,937
-30% -$13.1K
VTNR
10557
DELISTED
Vertex Energy, Inc
VTNR
$34K ﹤0.01%
48,383
+37,843
+359% +$21.5K
DXYN
10558
DELISTED
Dixie Group Inc
DXYN
$34K ﹤0.01%
+13,215
New +$22.5K
CLIR icon
10559
ClearSign Technologies
CLIR
$27.9M
$33K ﹤0.01%
+1,128
New +$29.3K
NMTR
10560
PUT
DELISTED
9 Meters Biopharma
NMTR
$33K ﹤0.01%
+1,895
New +$31.6K
RJN
10561
DELISTED
AB Svensk Ekportkredit ELEMENTS Linked to the Rogers International Commodity Index-Energy Total Return
RJN
$33K ﹤0.01%
20,469
-9,101
-31% -$13.6K
BBAR icon
10562
CALL
BBVA Argentina
BBAR
$3.21B
$32K ﹤0.01%
10,100
-7,900
-44% -$23.4K
BDRX
10563
Biodexa Pharmaceuticals
BDRX
$1.54M
0
ERNA icon
10564
Eterna Therapeutics
ERNA
$5.1M
$32K ﹤0.01%
+1
New +$30.4K
GRNQ icon
10565
Greenpro Capital
GRNQ
$32K ﹤0.01%
+157
New +$2.42K
MDRR
10566
Medalist Diversified Inc
MDRR
$18.7M
$32K ﹤0.01%
+906
New +$30.4K
SCTL
10567
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$32K ﹤0.01%
+11,134
New +$25.1K
CWBR
10568
DELISTED
CohBar, Inc. Common Stock
CWBR
$32K ﹤0.01%
+789
New +$26.7K
SPNV.WS
10569
DELISTED
Supernova Partners Acquisition Company, Inc. Warrants, each whole warrant exercisable for one share
SPNV.WS
$32K ﹤0.01%
+15,716
New +$35.3K
PRPO icon
10570
Precipio
PRPO
$41.9M
$31K ﹤0.01%
+751
New +$33.1K
RAIL icon
10571
PUT
FreightCar America
RAIL
$245M
$31K ﹤0.01%
+13,000
New +$28.5K
DTEA
10572
DELISTED
DAVIDsTEA Inc. Common Stock
DTEA
$31K ﹤0.01%
+12,855
New +$20.2K
IO
10573
DELISTED
ION Geophysical Corporation
IO
$31K ﹤0.01%
+12,657
New +$23.8K
KRKR
10574
36Kr Holdings
KRKR
$6.12M
$30K ﹤0.01%
+542
New +$32K
SVRA icon
10575
Savara
SVRA
$1.08B
$30K ﹤0.01%
26,242
-445
-2% -$536

Similar funds

Ken Griffin's Q4 2020 Portfolio in Review

As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.

  • Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
  • Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
  • Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
  • Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
  • Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
  • Ken Griffin opened 1,989 new positions and closed 1,130 in Q4 2020.
  • Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.

Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.